MP
GRDN

Mangrove Partners’s Guardian Pharmacy Services GRDN Stock Holding History

Mangrove Partners’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$499K Buy
+13,249
New +$433K 0.04% 201

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Mangrove Partners's GRDN Position: Q1 2026 in Review

Mangrove Partners opened a new position in Guardian Pharmacy Services (GRDN) in Q1 2026: 13,249 shares worth $499K. The stake represents 0.04% of the portfolio and ranks #201 among its holdings.

171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Mangrove Partners held 13,249 shares of Guardian Pharmacy Services worth $499K as of Q1 2026.
  • Guardian Pharmacy Services was a new Mangrove Partners position in Q1 2026.
  • Guardian Pharmacy Services made up 0.04% of Mangrove Partners's portfolio in Q1 2026, its #201 holding.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Mangrove Partners's 13F filing for Q1 2026, filed 15 May 2026.